New program aims to boost heart health in psychosis patients

NCT ID NCT06781801

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a program called LAGOM designed to improve heart health and quality of life for people with psychotic disorders. 644 adults from six clinics in Gothenburg will either receive the LAGOM program or standard care. The program includes regular check-ups, motivational tools, and support from a team of health professionals to help manage weight, blood pressure, and cholesterol over 36 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSYCHOTIC DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Psykosmottagning Centrum

    RECRUITING

    Gothenburg, 411 13, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Psykosmottagning Hisingen

    RECRUITING

    Gothenburg, 417 52, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Psykosmottagning Mölndal

    RECRUITING

    Mölndal, 431 35, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Psykosmottagning Nordost

    RECRUITING

    Gothenburg, 415 05, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Psykosmottagning Väster

    RECRUITING

    Gothenburg, 421 48, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Psykosmottagning Öster

    RECRUITING

    Gothenburg, 416 72, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.